Figure S4 from Treatment of prostate cancer with CD46 targeted ²²⁵Ac alpha particle radioimmunotherapy

Anil P. Bidkar; Sinan Wang; Kondapa Naidu Bobba; Emily Chan; Scott Bidlingmaier; Emily A. Egusa; Robin Peter; Umama Ali; Niranjan Meher; Anju Wadhwa; Suchi Dhrona; Chandrashekhar Dasari; Denis Beckford-Vera; Yang Su; Ryan Tang; Li Zhang; Jiang He; David M. Wilson; Rahul Aggarwal; Henry F. VanBrocklin; Youngho Seo; Jonathan Chou; Bin Liu; Robert R. Flavell

doi:10.1158/1078-0432.27030397.v1

Abstract

Figure S4: Gamma energy spectra of the tumor, blood, kidneys, and bone showing the intensities of the 213Bi and 221Fr peaks. As compared to the equilibrium gamma energy spectra of [225Ac]DOTA-YS5, increased intensity of the 213Bi was observed in kidney samples.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bidkar et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db6435875239ef https://doi.org/10.1158/1078-0432.27030397.v1

View at Publisher

Ask AI

Bookmark

Share

Figure S4 from Treatment of prostate cancer with CD46 targeted ²²⁵Ac alpha particle radioimmunotherapy

Abstract

Discussion

Cite This Study

Figure S4 from Treatment of prostate cancer with CD46 targeted ²²⁵Ac alpha particle radioimmunotherapy

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers